Insulet (PODD) Net Margin Growth (1y) (2011 - 2026)
Insulet (PODD) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 656.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -430.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 201.00 |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 572.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 572.00 |
| Dec 31, 2025 | -388.00 |
| Sep 30, 2025 | -185.00 |
| Jun 30, 2025 | -3,514.00 |
| Mar 31, 2025 | -542.00 |
| Dec 31, 2024 | -343.00 |
| Sep 30, 2024 | 225.00 |
| Jun 30, 2024 | 3,172.00 |
| Mar 31, 2024 | 501.00 |
| Dec 31, 2023 | 1,568.00 |
| Sep 30, 2023 | 1,352.00 |
| Jun 30, 2023 | 1,858.00 |
| Mar 31, 2023 | -276.00 |
| Dec 31, 2022 | -489.00 |
| Sep 30, 2022 | -634.00 |
| Jun 30, 2022 | -207.00 |
| Dec 31, 2021 | 1,644.00 |
| Sep 30, 2021 | -14.00 |
| Jun 30, 2021 | -1,598.00 |
| Dec 31, 2020 | -934.00 |